Option Care Health, Inc. (NASDAQ:OPCH) Receives $33.00 Consensus Target Price from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have received a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $33.00.

Several equities research analysts have issued reports on OPCH shares. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. lifted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research lifted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. JMP Securities reissued a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.64% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp purchased a new position in Option Care Health during the 4th quarter valued at $26,000. UMB Bank n.a. boosted its holdings in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC boosted its holdings in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after buying an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC boosted its holdings in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after buying an additional 1,099 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after buying an additional 332 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Trading Up 2.3 %

Shares of Option Care Health stock opened at $33.56 on Thursday. Option Care Health has a 1 year low of $21.39 and a 1 year high of $35.53. The firm has a market cap of $5.51 billion, a PE ratio of 28.20, a PEG ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The company has a 50 day simple moving average of $33.17 and a two-hundred day simple moving average of $28.58.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.